Tranexamic Acid Use Is Associated With Lower Rates of Transfusion in Patients Undergoing Revision Total Hip Arthroplasty for Periprosthetic Joint Infection
Sahil S. Telang, Julian Wier, Pranit Kumaran, Steven H. Liu, Jacob Becerra, Jay R. Lieberman, Nathanael D. Heckmann · 2026
Read Tranexamic Acid Use Is Associated With Lower Rates of Transfusion in Patients Undergoing Revision Total Hip Arthroplasty for Periprosthetic Joint Infection by Sahil S. Telang, Julian Wier, Pranit Kumaran, Steven H. Liu, Jacob Becerra, Jay R. Lieberman, Nathanael D. Heckmann (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13495081.txt.
Description
A peer-reviewed research article from Europe PMC (2026). BackgroundWhile tranexamic acid (TXA) is widely used in primary total hip arthroplasty (THA), it has not been studied extensively during revision THA for periprosthetic joint infection (PJI). Since revision procedures for infection are associated with greater intraoperative blood loss and a higher likelihood of transfusion, investigation of TXA use in first-stage revision THA for PJI is warranted to define its impact on postoperative bleeding risk, transfusion requirements, and safety profile.MethodsQuerying a large healthcare database, we identified adult patients between 2016 and 2023
Catalog record
| CREATOR | Sahil S. Telang, Julian Wier, Pranit Kumaran, Steven H. Liu, Jacob Becerra, Jay R. Lieberman, Nathanael D. Heckmann |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 28 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |